×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Crown Laboratories Announces Completion of Acquisition of Revance Therapeutics
PR Newswire
Crown Laboratories, Inc. (Crown), a privately held, global innovative leader in the skincare industry, today announced the successful closing of its...
5 months ago
Revance Names New CEO to Drive Next Phase in Aesthetic Innovation
Global Cosmetics News
Revance Therapeutics has announced a leadership succession plan, with founder and CEO Jeff Bedard transitioning to the role of Executive Chairman.
1 month ago
Johnson City-based Crown Labs now operating as ‘Revance’
WJHL
Crown Laboratories, a Johnson City-based skincare and aesthetics producer, will operate under a new name, effective immediately.
3 months ago
Revance agrees to lower take-private offer by Crown Labs
Reuters
Crown Laboratories would buy the anti-wrinkle injection maker Revance Therapeutics (RVNC.O) at a roughly 50% lower price compared to an original agreement...
7 months ago
Crown Laboratories Completes Acquisition of Revance Therapeutics
Business Wire
Crown Laboratories, Inc. (Crown), a Hildred Capital portfolio company and privately held, global innovative leader in the skincare industry, announced the...
5 months ago
Major Aesthetics Deal: Crown Labs Acquires Revance as Shareholders Cash Out at Premium
Stock Titan
Crown Laboratories Announces Completion of Acquisition of Revance Therapeutics ... Crown Laboratories has successfully completed its acquisition...
5 months ago
Crown Laboratories and Revance Amend the A&R Merger Agreement to Increase Offer Price to $3.65 per Share and Extend Existing Tender Offer
Yahoo Finance
Crown Laboratories and Revance Amend the A&R Merger Agreement to Increase Offer Price to $3.65 per Share and Extend Existing Tender Offer.
5 months ago
Crown Labs Tops Rival Bid In Quest To Buy Biotech Revance
Law360
Skincare product company Crown Laboratories Inc. has offered to raise its all-cash bid to buy healthcare biotech company Revance Therapeutics Inc. from $3.10...
5 months ago
Crown Laboratories rebrands as Revance following acquisition
WCYB
Crown Laboratories announced Monday that it is now operating under the name Revance. This rebranding follows the company's recent acquisition of Revance...
3 months ago
Revance Announces Blue Lizard® Australian Sunscreen Times Square Takeover to Celebrate National Sunscreen Day
Morningstar
The updated formulas feature 100% mineral active ingredients and are free from fragrances, parabens, phthalates, oxybenzone, and octinoxate –...
1 month ago